CAPN1
Basic information
Region (hg38): 11:65180566-65212006
Links
Phenotypes
GenCC
Source:
- autosomal recessive spastic paraplegia type 76 (Strong), mode of inheritance: AR
- autosomal recessive spastic paraplegia type 76 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Spastic paraplegia 76, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 27153400 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (225 variants)
- Inborn_genetic_diseases (88 variants)
- Autosomal_recessive_spastic_paraplegia_type_76 (35 variants)
- CAPN1-related_disorder (6 variants)
- not_specified (5 variants)
- Hereditary_spastic_paraplegia_11 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAPN1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005186.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 54 | 61 | ||||
| missense | 137 | 10 | 153 | |||
| nonsense | 10 | 18 | ||||
| start loss | 0 | |||||
| frameshift | 11 | |||||
| splice donor/acceptor (+/-2bp) | 10 | |||||
| Total | 28 | 16 | 137 | 64 | 8 |
Highest pathogenic variant AF is 0.000105541556
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CAPN1 | protein_coding | protein_coding | ENST00000527323 | 21 | 31441 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 5.86e-10 | 1.00 | 124649 | 0 | 71 | 124720 | 0.000285 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.68 | 369 | 472 | 0.782 | 0.0000315 | 4636 |
| Missense in Polyphen | 135 | 194.01 | 0.69583 | 1899 | ||
| Synonymous | 2.48 | 149 | 193 | 0.773 | 0.0000134 | 1354 |
| Loss of Function | 3.16 | 23 | 46.1 | 0.499 | 0.00000257 | 470 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00155 | 0.00154 |
| Ashkenazi Jewish | 0.000204 | 0.000199 |
| East Asian | 0.000112 | 0.000111 |
| Finnish | 0.000140 | 0.000139 |
| European (Non-Finnish) | 0.000214 | 0.000212 |
| Middle Eastern | 0.000112 | 0.000111 |
| South Asian | 0.000233 | 0.000229 |
| Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. {ECO:0000269|PubMed:21531719, ECO:0000269|PubMed:2400579}.;
- Disease
- DISEASE: Spastic paraplegia 76, autosomal recessive (SPG76) [MIM:616907]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:27153400}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Alzheimer,s disease - Homo sapiens (human);Necroptosis - Homo sapiens (human);Apoptosis - Homo sapiens (human);Cellular senescence - Homo sapiens (human);Integrin-mediated Cell Adhesion;Alzheimers Disease;Keratinization;Developmental Biology;Neutrophil degranulation;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;erk and pi-3 kinase are necessary for collagen binding in corneal epithelia;ucalpain and friends in cell spread;integrin signaling pathway;deregulation of cdk5 in alzheimers disease;mcalpain and friends in cell motility;Extracellular matrix organization;Innate Immune System;Immune System;Degradation of the extracellular matrix;Formation of the cornified envelope;Signaling events mediated by PTP1B
(Consensus)
Recessive Scores
- pRec
- 0.340
Intolerance Scores
- loftool
- 0.500
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.82
Haploinsufficiency Scores
- pHI
- 0.572
- hipred
- Y
- hipred_score
- 0.758
- ghis
- 0.565
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.624
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Capn1
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- capn1a
- Affected structure
- neuron
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- proteolysis;positive regulation of cell population proliferation;regulation of macroautophagy;receptor catabolic process;neutrophil degranulation;regulation of catalytic activity;mammary gland involution;cornification;self proteolysis;regulation of NMDA receptor activity
- Cellular component
- extracellular region;cytoplasm;mitochondrion;lysosome;cytosol;plasma membrane;focal adhesion;membrane;extracellular exosome;ficolin-1-rich granule lumen
- Molecular function
- endopeptidase activity;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding;protein binding